Skip to main content
| News

New innovation campus to be named Switzerland Innovation Park Basel Area Main Campus

21.04.2021

A new innovation campus is currently under construction in Allschwil. This will be known as Switzerland Innovation Park Basel Area Main Campus. It will be ready for business in summer 2022.

Switzerland Innovation Park Basel Area Main Campus
Courtyard of the Switzerland Innovation Park Basel Area Main Campus (Visualization: Herzog & de Meuron)

The real estate development firm Senn Resources AG is in the process of constructing a new building in Allschwil in the canton of Basel-Landschaft that from next summer onwards will be home to innovative start-ups and established companies. This was actually supposed to have been known as the GRID Campus of Collaboration. However, the name has now been changed, details of which can be found in a press release. The building will open its doors as the Switzerland Innovation Park Basel Area Main Campus in summer 2022.

Switzerland Innovation Park Basel Area, which is operated by the investment and innovation promotion agency Basel Area Business & Innovation, currently has four locations: Allschwil and Jura in addition to two sites in Basel. The new building under construction in Allschwil is to become the new headquarters from next year. “We are very proud that the new building will carry the name Switzerland Innovation Park Basel Area and at the same time will become its Main Campus”, comments Johannes Senn, CEO of Senn Resources, in the press release.

Switzerland Innovation Park Basel Area will also become a strategic partner and anchor tenant of the new innovation campus. It has agreed to rent and expand 6,000 square meters of the overall usable space of 50,000 square meters, where both start-ups and established companies will be invited to set up shop.

The Switzerland Innovation Park Basel Area is therefore making a contribution to consolidating the life sciences cluster in the Basel Area. After all, companies such as Johnson & Johnson and Idorsia are already based just a stone’s throw away from the new Main Campus in Allschwil. The Main Campus is set to house the Department of Biomedical Engineering of the University of Basel, CSEM, Basilea Pharmaceutica and Hamilton Bonaduz AG, among other enterprises.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.